Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Hamanou Benachour"'
Autor:
Tareck Rharass, Laura Entz, Adrien Tonione, Hamanou Benachour, Damien Leterme, Christophe Chauveau, Gilles Pasquier, Stéphanie Lucas
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100486- (2020)
Externí odkaz:
https://doaj.org/article/4dcd80eac82b4d5db4c60d11d7d43c1e
Publikováno v:
Theranostics, Vol 2, Iss 9, Pp 889-904 (2012)
Photodynamic therapy (PDT) is an emerging theranostic modality for various cancer as well as non-cancer diseases. Its efficiency is mainly based on a selective accumulation of PDT and imaging agents in tumor tissue. The vascular effect is widely acce
Externí odkaz:
https://doaj.org/article/445adf082ed24719826740f83d7d2fe7
Autor:
Hamanou Benachour, Thierry Bastogne, Magali Toussaint, Yosra Chemli, Aymeric Sève, Céline Frochot, François Lux, Olivier Tillement, Régis Vanderesse, Muriel Barberi-Heyob
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48617 (2012)
Nanoparticles are widely suggested as targeted drug-delivery systems. In photodynamic therapy (PDT), the use of multifunctional nanoparticles as photoactivatable drug carriers is a promising approach for improving treatment efficiency and selectivity
Externí odkaz:
https://doaj.org/article/a7a7a19e66334ef5856d4baf1653325a
Autor:
Gilles Pasquier, Tareck Rharass, Adrien Tonione, Hamanou Benachour, Damien Leterme, Christophe Chauveau, Stéphanie Lucas, Laura Entz
Publikováno v:
Bone Reports, Vol 13, Iss, Pp 100486-(2020)
Autor:
Elise Jeannesson, Hamanou Benachour, B. Bastien, Sophie Visvikis-Siest, Anastasia Samara, Daniel Lambert, Bernard Herbeth, Gérard Siest
Publikováno v:
Personalized medicine. 4(1)
Autor:
Hamanou Benachour, Johanne Leroy-Dudal, Jarad J. Wilson, Olivier Gallet, Rémy Agniel, Franck Carreiras, Mélanie Briand
Publikováno v:
Journal of Molecular Recognition
Journal of Molecular Recognition, Wiley, 2018, 31 (5), ⟨10.1002/jmr.2690⟩
Journal of Molecular Recognition, Wiley, 2018, 31 (5), ⟨10.1002/jmr.2690⟩
Changes in glycosylation have been associated with human cancer, but their complexity poses an analytical challenge. Ovarian cancer is a major cause of death in women because of an often late diagnosis. At least one-third of patients presents ascites
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c833e5ec2cabe7ec331afe3c32149f26
Autor:
Laurent Poulouin, Hamanou Benachour, Charlotte Vendrely, Olivier Gallet, Rümeyza Bascetin, Rémy Agniel, Johanne Leroy-Dudal
Publikováno v:
Journal of Molecular Recognition. 28:731-741
Fibronectin, a ≈450-kDa protein with 4–9% (w/w) glycosylation, is a key component of extracellular matrices and has a high conformational lability regarding its functions. However, the accessibility and the role of glycosylated moieties associate
Autor:
Nabila Belhaj, Mohamed Hasan, Elmira Arab-Tehrany, Cyril J.F. Kahn, Esmaiel Jabbari, Muriel Barberi-Heyob, Hamanou Benachour, Michel Linder
Publikováno v:
International Journal of Pharmaceutics
International Journal of Pharmaceutics, 2014, 461 (1-2), pp.519-528. ⟨10.1016/j.ijpharm.2013.12.007⟩
International Journal of Pharmaceutics, Elsevier, 2014, 461 (1-2), pp.519-528. ⟨10.1016/j.ijpharm.2013.12.007⟩
International Journal of Pharmaceutics, 2014, 461 (1-2), pp.519-528. ⟨10.1016/j.ijpharm.2013.12.007⟩
International Journal of Pharmaceutics, Elsevier, 2014, 461 (1-2), pp.519-528. ⟨10.1016/j.ijpharm.2013.12.007⟩
International audience; The role of curcumin (diferuloylmethane), for cancer treatment has been an area of growing interest. However, due to its low absorption, the poor bioavailability of curcumin limits its clinical use. In this study, we reported
Autor:
Djahida Sidane, Mahfoud Boustta, Franck Carreiras, Hafit Khireddine, Mathilde Hindié, Olivier Gallet, Hamanou Benachour, Sabeha Yala
Publikováno v:
Journal of Materials Science: Materials in Medicine
Journal of Materials Science: Materials in Medicine, Springer Verlag, 2016, 27 (9), ⟨10.1007/s10856-016-5756-8⟩
Journal of Materials Science: Materials in Medicine, Springer Verlag, 2016, 27 (9), ⟨10.1007/s10856-016-5756-8⟩
A novel synthetic method to synthesize hydroxyapatite/poly (D,L) lactic acid biocomposite is presented in this study by mixing only the precursors hydroxyapatite and (D,L) LA monomer without adding neither solvent nor catalyst. Three compositions wer
Publikováno v:
Current Pharmaceutical Design. 15:3193-3206
The growing knowledge about genetic influence on cardiovascular diseases (CVD) combined with the recently generated amounts of genomic data hold promise to the identification of new markers for atherosclerotic CVD. Cardiovascular pharmacogenomics and